PTGS2 and tuberous sclerosis: It is therefore reasonable to assume that combined administration of COX2 inhibitors with rapamycin would help to eliminate the unwanted effects of the upregulated COX2 and improve the antitumor effect of rapamycin in the treatment of TSC.